Metacrine Inc. (MTCR): Price and Financial Metrics Recent IPO
Metacrine Inc. (MTCR) Recent IPO
Today's Latest Price: $8.50 USD
Updated Nov 24 4:00pm
Add MTCR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
MTCR Stock Price Chart Interactive Chart >
MTCR Price/Volume Stats
| Current price | $8.50 | 52-week high | $16.19 |
| Prev. close | $8.73 | 52-week low | $8.05 |
| Day low | $8.34 | Volume | 39,000 |
| Day high | $8.74 | Avg. volume | 95,614 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 220.63M |
Metacrine Inc. (MTCR) Company Bio
Metacrine, Inc. is a clinical-stage biopharmaceutical company that engages in the discovery and development of differentiated therapies for patients with liver and gastrointestinal diseases. Its farnesoid X receptor, or FXR, is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.
Loading social stream, please wait...